Algamed Therapeutics

Bioactive Platform for Treatment of Vaginal Dryness

Health Tech & Life Sciences
Active
Seed Rosh Pinna Founded 2014
Total raised
$910K
Last: Equity crowdfunding 2021-09
Stage
Seed
Founded
2014
Headcount
1
HQ
Rosh Pinna
Sector
Health Tech & Life Sciences

About

Algamed Therapeutics specializes in developing technologies dedicated to treating common vaginal conditions, such as dryness, vaginal infections (including yeast infections), menstrual cramps, dyspareunia, and hopefully endometriosis.

The company's first product is Secret de Joie, a natural, hormone-free jelly for treating vaginal dryness. Secret de Joie is intended for breast and ovarian cancer survivors who must avoid taking hormones and women who are postmenopausal, breastfeeding, diabetic, taking birth control pills, and more. The product relieves the dryness that causes discomfort and interferes with intercourse and helps to restore the affected skin.

Funding history · 1 round · $910K total

2021-09
Equity crowdfunding $910K

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Algamed Therapeutics' primary focus?
Algamed Therapeutics specializes in developing technologies for treating common vaginal conditions, including dryness, infections, menstrual cramps, and dyspareunia.
What is Algamed Therapeutics' first product?
Algamed Therapeutics' first product is Secret de Joie, a natural, hormone-free jelly designed to treat vaginal dryness.
Who is the target demographic for Secret de Joie?
Secret de Joie is intended for breast and ovarian cancer survivors who need to avoid hormones, as well as postmenopausal, breastfeeding, diabetic women, and those taking birth control pills.
When was Algamed Therapeutics founded?
Algamed Therapeutics was founded in August 2014.
What is the total amount of funding Algamed Therapeutics has raised?
Algamed Therapeutics has raised a total of $910,000 USD. For a full financing history, please refer to startupim.
When did Algamed Therapeutics complete its last funding round and what type was it?
In September 2021, Algamed Therapeutics completed an Equity crowdfunding round, raising $910,000 USD.
Which investor participated in Algamed Therapeutics' equity crowdfunding round?
PipelBiz was an investor in Algamed Therapeutics' equity crowdfunding round in September 2021.
How many employees does Algamed Therapeutics currently have?
Algamed Therapeutics currently has between 1 and 10 employees.
Has Algamed Therapeutics received any grants?
Algamed Therapeutics has received a grant from the IIA.
What is Algamed Therapeutics' current product stage?
Algamed Therapeutics' product, Secret de Joie, is currently released.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMicroorganisms
Target customers
Commerce & RetailDistribution ChannelsDistributorConsumersDemographics & FamilyWomen
Business model
B2CB2B2C

Highlights

1 PatentsVerified

Tags

femtechwomen-healthalgaeanti-inflammatorywomendrug-developmentbiopharmaceuticalpain-relief